4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0001140361-15-037812
$CTMXCIK 0001501989operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 10:17 AM ET
Size
9.4 KB
Accession
0001140361-15-037812
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Award
Employee Stock Option (right to buy)
2015-05-07+246,042→ 246,042 totalExercise: $1.57Exp: 2025-02-08→ Common Stock (246,042 underlying) - Purchase
Common Stock
2015-10-14$12.00/sh+5,000$60,000→ 5,000 total - Award
Emploiyee Stock Option (right to buy)
2015-08-26+85,605→ 85,605 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (85,605 underlying)
Footnotes (2)
- [F1]This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.
- [F2]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 10:17 AM ET
- Size
- 9.4 KB